# Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

> **NCT05475171** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Metastatic Cancer
- Cervical Cancer

## Interventions

- **DRUG:** Lorigerlimab

## Key facts

- **NCT ID:** NCT05475171
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-13
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05475171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05475171, "Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05475171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*